BOSTON – PhysIQ and Vital Connect are working together in a pilot to evaluate how clinician visits to homes, combined with advanced continuous patient monitoring, can potentially replace hospitalizations for common medical admissions.
“The evolution of digital medicine makes us even more confident in the home hospital model for our patients,” said Dr. David Levine, the study’s principal investigator, in a statement. “We are in a very exciting era of medicine where clinical-grade biosensors and analytics are capable of delivering continuous physiological insight that was traditionally only available in the hospital environment.”
The pilot is taking place at Partners HealthCare Brigham and Women’s Hospital. It is the first of two planned initiatives to evaluate how technology and home-based care delivery can be leveraged to treat patients who would otherwise be admitted to the hospital.
As part of the randomized controlled trial, patients diagnosed at the BWH Emergency Department with exacerbation of heart failure, pneumonia, COPD, cellulitis or complicated urinary tract infection are provided with a home monitoring solution that includes the Vital Connect VitalPatch biosensor and physIQ Personalized Physiology Analytics platform.
“It’s extremely gratifying to know that leading institutions like Partners HealthCare and Brigham and Women’s Hospital are embracing the transformational potential of digital medicine,” said Gary Conkright, CEO of physIQ, in a press release.
The first phase of the pilot began in mid-September and involves up to 60 patients. Half of the patients are receiving traditional in-hospital treatment and half are receiving treatment at home. The pilot will scale up to 500 patients early next year.
“We see this initiative as proof of a new era of medicine,” said Dr. Nersi Nazari, CEO of Vital Connect, in a statement. “One where transformational models of care delivery are enabled by continuous ambulatory monitoring technology.”